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Abstract Contagious bovine pleuropneumonia (CBPP), a se-
vere respiratory disease, is characterized by massive inflam-
mation of the lung especially during the acute clinical stage of
infection. Tissue samples from cattle, experimentally infected
withMycoplasmamycoides subsp.mycoidesAfadé, were sub-
jected to histopathological and immunohistochemical exami-
nation in order to provide insight into innate immune path-
ways that shape inflammatory host responses. Lung lesions
were characterized by vasculitis, necrosis, and increased pres-
ence of macrophages and neutrophils, relative to uninfected
animals. The presence of three cytokines associated with
innate inflammatory immune responses, namely, IL-1β, IL-
17A, and TNF-α, were qualitatively investigated in situ.
Higher cytokine levels were detected in lung tissue samples
from CBPP-affected cattle compared to samples derived from
an uninfected control group. We therefore conclude that the
cytokines TNF-α and IL-1β, which are prevalent in the acute
phase of infections, play a role in the inflammatory re-
sponse seen in the lung tissue in CBPP. IL-17A gets
released by activated macrophages and attracts
granulocytes that modulate the acute phase of the
CBPP lesions.
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Abbreviations
BALT Bronchoalveolar lymphoid tissue
CBPP Contagious bovine pleuropneumonia
dpi Days post infection
IACUC Institutional Animal Care and Use Committee
IL-1β Interleukin-1 beta
IL-17A Interleukin-17A
ILRI International Livestock Research Institute
Mmm Mycoplasma mycoides subsp. mycoides
TNF-α Tumor necrosis factor alpha
Introduction
Contagious bovine pleuropneumonia (CBPP) is a severe re-
spiratory disease in cattle that is present in many countries in
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sub-Saharan Africa. CBPP is caused by Mycoplasma
mycoides subsp. mycoides (Mmm), a member of the
BMycoplasma mycoides cluster^ (Fischer et al. 2012) which
in addition to Mmm comprises four related mycoplasma line-
ages, i.e., M. mycoides subsp. capri, M. capricolum subsp.
capricolum, M. capricolum subsp. capripneumoniae, and M.
leachii. Besides having a negative impact on the productivity
of pastoral cattle farming systems, CBPP is a disease of both
regional and international trade, limiting the marketability of
cattle in affected regions or countries, consequently resulting
in substantial financial losses that negatively impact the live-
lihood of many people in sub-Saharan Africa (Jores et al.
2013; Thiaucourt et al. 2004b). Cattle infected with Mmm
can develop acute, subacute, or chronic disease. Acute
CBPP is characterized by pyrexia, anorexia, and respiratory
signs including rapid and painful breathing and occasionally
coughing. Furthermore, large quantities of pleural fluid con-
taining high numbers of mycoplasma are often found during
necropsy (Weldearegay et al. 2015). Cattle that exhibit acute
disease can either clear the infection, become chronically in-
fected, or die. The current live vaccine against CBPP T1/44
occasionally causes severe side effects at the site of inocula-
tion and, most importantly, lacks efficacy and confers immu-
nity only for up to 1 year, which makes repeated vaccinations
essential (Thiaucourt et al. 2004a). The development and sub-
sequent implementation of an improved vaccine, which con-
fers immunity for more than 1.5 years, would greatly benefit a
progressive control of CBPP (Ssematimba et al. 2015).
However, an increased understanding of the host-pathogen
interactions including protective host immune responses is a
prerequisite for the rational design of novel vaccines (Jores et
al. 2013). Several previous studies have been performed in
order to identify how host mechanisms confer immunity to
CBPP. The importance of both humoral and T cell-mediated
immune responses in mediating protection has been de-
scribed. Interferon gamma-secreting CD4+ T cells have been
associated with protection against CBPP during primary in-
fections (Dedieu et al. 2005). These results could however not
be confirmed by Jores et al. (2008) and Sacchini et al. (2011),
though it is likely that specific CD4+ T cell subsets are in-
volved in immunity (Totte et al. 2010, 2008).
Typical CBPP lesions show a fibrinous pleuropneumonia
and represent a lobar and lobular pneumonia which usually
undergoes acute progression. Classically, the CBPP has four
stages. (1) Congestion occurs in the first 24 h postinfection.
This stage is characterized histologically by vascular engorge-
ment, intraalveolar fluid, small numbers of neutrophils, and
infectious agents. Grossly, the lung is severely hyperemic. (2)
Red hepatization or consolidation includes vascular conges-
tion with extravasation of red cells into alveolar spaces, along
with increased numbers of neutrophils and fibrin. The filling
of alveoli by the exudate leads to a gross appearance of solid-
ification, or consolidation, of the alveolar parenchyma. (3)
The stage of grey hepatization is characterized by disintegra-
tion of red blood cells, with persistence of the neutrophils and
fibrin. The alveoli still appear consolidated, but grossly the
color is paler and the cut surface is drier. (4) In the stage of
resolution, the pulmonary tissue shows complete recovery.
Stages 1 and 2 (congestion, red hepatization) represent more
acute pathological findings, whereas stage 3 (grey
hepatization) describes chronical pathological findings.
Congestion and red and grey hepatization can occur within
one individual in parallel at the same time.
Sequestra in the pulmonary parenchyma are a characteristic
of chronically diseased animals. They consist of a layer of
fibrous tissue enclosing necrotic cells, which is composed of
a purulent exudate and live Mycoplasma (Caswell and
Williams 2007; Schieck et al. 2014). An increased presence
of myeloid cells in affected lung tissue was observed in a
previous study, though numbers were low (Jores et al. 2008).
Despite a large number of experimental infections performed
in the past, documentation of pathological lesions with respect to
the in situ presence of distinct host immune cells as well as the
presence of cytokines is still lacking. Here, we investigated
lungs, mediastinal lymph nodes, and kidneys from ten cattle
experimentally infected with CBPP (Sacchini et al. 2011) using
standard histologic procedures and immunocytochemistry. The
presence of Mmm was confirmed using rabbit polyclonal anti-
bodies. Furthermore, we investigated the in situ presence of the
inflammatory cytokines tumor necrosis factor alpha (TNF-α),
interleukin-1 beta (IL-1β), and interleukin-17A (IL-17A) in ex-
perimentally infected and non-infected animals. The data re-
vealed an increase in inflammatory cytokine expression in lung
tissues in infected animals compared to non-infected animals.
Materials and methods
Ethical considerations
The protocols used in this study were designed and performed
in strict accordance with the Kenyan legislation for Animal
Experimentation and were approved by the Institutional
Animal Care and Use Committee (IACUC reference number
2008.08 [bovine experimental infection] and 2008.14 [rabbit
polyclonal antibodies]). Since 1993, the International
Livestock Research Institute (ILRI) has complied voluntarily
with the United Kingdom’s Animals (Scientific Procedures)
Act 1986 that contains guidelines and codes of practice for the
housing and care of animals used in scientific protocols.
Sample collection
The cattle population and the experimental procedure used in
the present study have been described in detail elsewhere
(Sacchini et al. 2011). In brief, Kenyan Boran bullocks (Bos
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indicus), 14 to 16months of age at sourcing, were kept at ILRI
campus for 2.5 months prior to the transfer to the Animal
Biosafety Level 2 facility. Upon arrival to ILRI, the animals
were dewormed and treated prophylactically against babesio-
sis and anaplasmosis. The cattle were revaccinated against
lumpy skin disease, anthrax, blackleg, and foot and mouth
disease. All animals were tested negative for presence of an-
tibodies against CBPP, East Coast fever, and trypanosomiasis.
The cattle were infected by intubation using M. mycoides
subsp. mycoides strain Afadé which has been described else-
where (Fischer et al. 2015). The animals were monitored daily
for up to 30 days post infection (dpi) when the cattle were
euthanized and subjected to postmortem analysis.
Necropsy
The necropsy was done according to a standard procedure
(Strafuss 1988). Specimens were taken from lung, mediastinal
lymph nodes, and kidneys and were subsequently transferred
to tubes containing 5 % buffered formalin solution. Tubes
were stored at room temperature until further processing.
Microbiological and serological analysis
Lung samples and carpal joint fluid and pleural fluid speci-
mens were used for culture isolation of Mmm while serocon-
version was confirmed using complement fixation test (CFT)
(CIRAD, France).
Polyclonal rabbit antibody production
For antigen preparation, Mmm strain Afadé was grown in
100 ml pleuropneumonia-like organism (PPLO) broth (BD
Difco™, Germany) supplemented with 20 % horse serum
(Sigma, Germany). Cells were pelleted using centrifugation
at 5000g for 20 min and resuspended in 1 ml of PBS. The cell
suspension was ruptured using zirconium beads (0.1 mm di-
ameter, Carl Roth, Germany) in a FastPrep® Instrument
(Qbiogene, Germany) three times for 40 s at intensity setting
5.0, followed by heat inactivation at 60 °C for 10min. A rabbit
was immunized with Mmm antigen mixed with the same vol-
ume of complete Freund’s adjuvant in the first round and the
same volume of incomplete Freund’s adjuvant for the booster
injection. Heat-inactivated antigen with adjuvant was injected
intradermally and subcutaneously (two depots each).
Immunizations were given 4 weeks apart. Preimmunization
sera were collected 2 weeks before initial immunization and




Formalin-buffered tissue samples were embedded in paraffin
wax and subsequently cut into 2-μm slices, using a rotary
microtome, and stained with hematoxylin and eosin (HE stain-
ing) according to standard protocols.
Table 1 Histopathological observations in lungs from cattle with CBPP revealed by hematoxylin eosin-stained tissues
Animal no. Lung Middle mediastinal
lymph nodes
Kidney




BD92 Necrosis Interstitial pneumonia, focal
fibrosis
Moderate follicular hyperplasia –
BD95 Dilated and oedematous interlobular
septa, necrosis
Fibrosis, chronic pleurisy,
hyperplasia of the BALT
Moderate follicular hyperplasia –
BD97 Fibrinous bronchopneumonia, dilated
and oedematous interlobular septa
– Moderate follicular hyperplasia –
BD102 Dilated and oedematous interlobular
septa








Mild follicular hyperplasia –
BD106 Dilated and oedematous interlobular
septa
Interstitial pneumonia Mild follicular hyperplasia Mild focal interstitial
nephritis
BD107 Fibrinous bronchopneumonia, dilated
and oedematous interlobular septa
Sequestration, fibrosis,
hyperplasia of the BALT
Moderate follicular hyperplasia –




BD115 Necrosis Fibrosis Mild follicular hyperplasia –
BD116 Dilated and oedematous interlobular
septa
Interstitial pneumonia, fibrosis Moderate follicular hyperplasia Mild focal interstitial
nephritis
a Focal areas of acute and chronic findings are present simultaneously within one individual (see BIntroduction^ section)
Trop Anim Health Prod (2016) 48:569–576 571
Immunocytochemistry employing three cytokine markers
has been carried out on paraffin-embedded lung tissues.
Bovine IL-1β, IL-17A, and TNF-α were detected by using
biotinylated rabbit anti-bovine IL-1β polyclonal antibody
Fig. 1 a Lung—a shows severe, necrotizing bronchiolitis, with severe
dense cellular, necrotic debris obstructing the bronchiolar lumen. The
remaining bronchiolar wall shows loss of epithelial cells and severe
infiltration of pulmonary and interstitial mixed inflammatory infiltrate
with loss of pulmonary structure. Arrows indicate delineation of
bronchiolar lining. b Lung—b shows intraalveolar proteinaceous,
fibrinous precipitates (arrows) with loss of pulmonary architecture as
well as thickened alveolar septa with mixed inflammatory, interstitial
infiltrates within alveolar septa and interstitial space. c Lung—c shows
a severe, necrotizing vasculitis of a pulmonary arteriole with loss of
vascular wall (arrows indicate remnants of necrotic vascular wall) and
severe, necrotic, cellular debris obliterating the vascular lumen. The
perivascular interstitial space shows perivascular, mixed inflammatory
cells and protein precipitates. d Lung—d shows perivascular pulmonary
fibrosis extending into the interstitial space, with immature extracellular
matrix and mixed inflammatory cells. Arrow indicates arterial media
hypertrophy. e Lung—e shows an intrapulmonary arteriole with an
adhesive, lumen-obstructing thrombus and media hypertrophy. Arrow
indicates wall of arteriole. f Lung—f shows severe chronic, diffuse
pleuritis with extensive subpleural fibrosis and neovascularization and
loss of pulmonary architecture. Arrow indicates pleural surface. g
Lung—g shows an interstitial inflammatory infiltrate composed of neu-
trophilic and eosinophilic granulocytes (arrows) within the interstitial
space of the lung. h Pulmonary lymphnode—h shows a pulmonary
lymph node with follicular hyperplasia and activated germinal centers
(arrows). Size standards are displayed in the lower right corner of each
picture: black represents 100 μm; grey represents 50 μm, and yellow
represents 20 μm
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(article no. ab23778, Abcam, UK), biotinylated rabbit anti-
bovine IL-17A polyclonal antibody (article no. PBB0277B-
050, Kingfisher Biotech, Inc., USA), and biotinylated rabbit
anti-bovine TNF-α polyclonal antibodies (article no.
AHP852B, AbD Serotec, Germany), respectively. The
SuperVision 2 HRP Single Species (DCS, Germany) was used
for detection of biotinylated rabbit and mouse antibodies.
Tissues were stained with an irrelevant antibody from the
same species to check non-specific binding, and no non-
specific binding was evident. Immunoreactive signals were
reddish-brown.
Infected animals, showing fibrinous (BD97 and BD107)
and non-fibrinous bronchopneumonia (BD92, BD95,
BD102, BD105, BD106, BD111, BD115, and BD116), and
non-infected animals (control) were compared. Cytokine-
positive cells were evaluated within ten non-overlapping,
high-power fields (×40 final magnification) on a single micro-
scope by one experienced pathologist. Sections were assessed
with the operator blind to clinical details. Macrophages and
granulocytes were easily recognizable by staining, size, and
morphologic characteristics. Fields containing parts of lym-
phoid aggregates, massive necrosis, or fibrosis were avoided.
Results
Clinical symptoms of CBPP such as fever and coughing
peaked between 12 and 15 dpi. One animal (BD97) showed
severe clinical symptoms and had to be euthanized before the
end of the experiment for animal welfare reasons. Infection
was confirmed by seroconversion via CFT and isolation of
Mmm from cultured lung tissues or pleural fluids (Sacchini
et al. 2011). At necropsy, typical CBPP lesions were observed
in nine out of ten animals. Most pathomorphological lesions
were unilaterally present in the left lung with a comparable
frequency in the apical and in the diaphragmatic lobe
(Sacchini et al. 2011). Only two animals had lesions in the
right lung or on both sides. Acute fibrinous bronchopneumo-
nia was only visible in animals BD97 and BD107. In addition,
animal BD97 contained a large amount of pleural fluid infect-
ed with Mycoplasma. The other animals showed mainly
chronic lesions with fibrosis and sequestrum formation. No
significant differences in the presence of γδ+ T cells, mono-
cytes, CD8+ T cells, neutrophils, B cells, or granulocytes
(Additional file 1) between CBPP animals showing fibrinous
or non-fibrinous bronchopneumonia were detected.
Macroscopically visible renal infarcts were present in three
animals (BD97, BD107, and BD116) (Table 1).
The histological findings in the lungs were character-
ized by a juxtaposition of more acute lesions in parallel to
more chronic morphological lesions. In the lung, bronchi
and bronchioli frequently contained cellular necrotic debris
with transmural full-thickness necrosis of bronchial and
bronchiolar walls (Fig. 1a). Besides fibrinous broncho-
pneumonia, alveolitis (Fig. 1b), and fibrinous pleuritis, di-
lated and oedematous, interlobular septa occurred in these
CBPP pulmonary lesions. Severe leukocytoclastic vasculi-
tis with full-thickness necrosis and lysis of the vascular
wall was observed within the pulmonary parenchyma
(Fig. 1c).
Blood vessels in the interstitial septa often showed throm-
bosis (Fig. 1e) and vasculitis (Fig. 1c). These fibrinous throm-
bi often contained leukocytes and macrophages. Occasionally
progressive organization of connective tissue and
neoangiogenesis within immature granulation tissue were ev-
ident in the lung (Fig. 1d, f). The stroma contained variable
amounts of neutrophils and lymphocytes and occasionally eo-
sinophilic granulocytes (Fig. 1g). Pulmonary lymph nodes of
all animals developed a moderate to severe follicular hyper-
plasia with activated germinal centers (Fig. 1h). Lung tissues
were evaluated using three different cytokine-specific
markers, and expression of the these three cytokines
(TNF-α, IL-1β, and IL-17A) were investigated. At least three
different sections of the lung showing pathomorphological
changes were evaluated semiquantitatively (Table 2). CBPP
lesions were characterized by increased levels of TNF-α, IL-
1β, and IL-17A compared to the group of five non-infected
animals (Fig. 2, Table 2).
Discussion
This study aimed to characterize morphological lesions in
animals experimentally infected with Mycoplasma mycoides
subsp. mycoides in greater detail, by employing HE staining
and immunocytochemistry.
Table 2 Semi-quantitative assessment of inflammatory cytokines in
the lung of infected and uninfected animals
Animal no. TNF-α IL-1β IL-17A
Negative control group (n= 5) − − −
BD92 ++ ++ ++
BD95 ++ ++ ++
BD97 +++ +++ +++
BD102 ++ ++ ++
BD105 ++ ++ ++
BD106 ++ ++ ++
BD107 ++ ++ ++
BD111 ++ ++ ++
BD115 ++ ++ ++
BD116 ++ ++ ++
Immunoreactive signal: ++ moderate (20–40/HPF); +++ severe (≥40/
HPF)
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The tissue samples investigated were derived from cattle
that had been successfully infected as shown by seroconver-
sion and the isolation of the causative agent from all animals
(Sacchini et al. 2011). The gross pathological lung lesions
reflected the typical pathological patterns described for
CBPP (Caswell and Williams 2007). Necrotic areas of the
pulmonary lymph nodes have also been previously reported
from animals showing acute clinical symptoms of CBPP
(Scanziani et al. 1997). Four out of ten animals in the present
study showed mild focal interstitial renal inflammation and
necrosis (Table 1) as reported elsewhere (Grieco et al. 2001).
Seven out of ten infected animals showed mild inflammation
of the liver parenchyma and interstitium. Other investigated
organs did not show any noteworthy findings. The lesions
characterized by HE staining confirmed previous findings re-
lated to CBPP. Altogether, the histological patterns observed
in the animals used in this study manifested similar lesions to
those observed in natural outbreaks.
The presence ofMycoplasma antigen in CBPP lesions was
also investigated. Rabbit polyclonal sera were used to detect
the presence of antigen. As expected, the presence of
Mycoplasma antigen in macrophages and in lung tissue was
confirmed (Fig. 2h).
The results obtained in this study varied within the group of
tested animals and could not be correlated with specific clin-
ical and pathomorphological data of individual animals. Thus,
Fig. 2 Representative qualitative
results of the detection of the
cytokines IL-1β, IL-17A, and
TNF-α. The following polyclonal
antibodies were used. a Anti- IL-
1β: Lung: control animal;
b Anti- IL-1β: Lung: acute CBPP
lesion; c Anti- IL-17A: Lung:
control animal; d Anti- IL-17A:
Lung: acute CBPP lesion;
e Anti- TNF-α: Lung: control
animal; f Anti- TNF-α: Lung:
acute CBPP lesion;
g Anti- Mycoplasma: Lung:
control animal; h Anti-
Mycoplasma: Lung: acute CBPP
lesion. Black bars in the lower
right corner of images in a–f is the
size standard representing
100 μm, black bars in images of
g, h represent 20 μm. Arrows
indicate positive immunoreactive
signals (reddish-brown)
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use of increased animal numbers in future studies may result
in correlations not identified here.
Since it has been indicated that antibody levels can correlate
with disease severity (Mulongo et al. 2015; Nicholas et al. 2009;
Schieck et al. 2014), immune-mediated vasculitis might be in-
volved in the pathogenesis of CBPP, which will require confir-
mation in future studies. It has been stated that the presence of
vasculitis in CBPP might be caused by antigen-antibody com-
plexes deposited in arterial walls (Thiaucourt et al. 2004b).
TNF-α plasma levels are increased in acute diseased animals
compared to animals with mild disease symptoms (Sacchini et
al. 2012). Therefore, the presence of TNF-α levels in the target
tissue was evaluated. As expected, elevated levels of TNF-α in
the lung tissues confirmed an involvement of the proinflamma-
tory cytokine in pathogenesis of CBPP as previously proposed
(Sacchini et al. 2012). Alveolar macrophages, residing in the
lungs, are likely to initiate a response after interaction with the
pathogen and be a source of TNF-α and proinflammatory cyto-
kines as indicated in previous in vitro experiments (Jungi et al.
1996). However, it is possible that a component of the CD8+ T
cell response also contributed to increased TNF-α levels
(Hamada et al. 2013). TNF-α is crucial in protection against other
respiratory infections such as tuberculosis. It has been shown that
TNF-α released from both macrophages and T cells contributes
in distinct ways to the sustained control of Mycobacterium
tuberculosis (Allie et al. 2013). A role for this cytokine in the
control of CBPP should be tested in future studies.
The presence of macrophages and granulocytes in CBPP le-
sions prompted us to investigate the presence of the cytokines
IL-1β and IL-17A, which are markers for innate immune re-
sponses and granulocyte-attracting molecules, respectively
(McAleer and Kolls 2014). Both cytokines were evidently pres-
ent in affected lung tissue and are likely to mediate the immune
responses observed in CBPP. An increase in IL-1β is likely to be
induced by alveolar macrophages or dendritic cells after contact
with mycoplasma molecules and will stimulate the acute phase
response and secretion of IL-17 by γδ+ T cells, natural killer
cells, or CD4+ T cells in case of a memory immune response.
One possible hypothesis is that IL-17 has major protective roles
in adaptive and innate responses (McAleer and Kolls 2014). In
respiratory infections, IL-17 recruits neutrophils to the site of
inflammation and affects lung epithelial cells by stimulating an-
timicrobial peptide secretion and mucus production (Newcomb
et al. 2013). In addition, memory Th17 cells are important in
adaptive immunity. However, in some cases IL-17 can drive
acute lung injury, as in experimental infection with the influenza
strain H1N1 (Li et al. 2012). If HIN1 is a representative model, it
is therefore possible that in CBPP, IL-17 could contribute to both
protective and deleterious effects.
To conclude, innate inflammatory responses have been ob-
served in affected lungs. The main drivers of the innate re-
sponse are likely to be macrophages, granulocytes, and to a
lesser extent epithelial cells. We confirmed elevated in situ
levels of the three proinflammatory cytokines IL-1β, IL-
17A, and TNF-α in lung tissues from cattle experimentally
infected with Mmm.
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